{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:02:20Z","timestamp":1791277340493,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.neuropharm.2008.09.013","type":"journal-article","created":{"date-parts":[[2008,10,8]],"date-time":"2008-10-08T14:55:32Z","timestamp":1223477732000},"page":"379-385","source":"Crossref","is-referenced-by-count":39,"title":["Anxiolytic profile of pregabalin on elicited hippocampal theta oscillation"],"prefix":"10.1016","volume":"56","author":[{"given":"Chester J.","family":"Siok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles P.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mih\u00e1ly","family":"Haj\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2008.09.013_bib1","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1021\/jm049762l","article-title":"Structure\u2013activity relationships of pregabalin and analogs that target the \u03b12\u2013\u03b4 protein","volume":"48","author":"Belliotti","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2005.12.084","article-title":"Calcium channel alpha2\u2013delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo autoradiographic study in alpha2\u2013delta type 1 genetically modified mice","volume":"1075","author":"Bian","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib3","doi-asserted-by":"crossref","first-page":"25458","DOI":"10.1074\/jbc.273.39.25458","article-title":"Cloning and deletion mutagenesis of the alpha2\u2013delta calcium channel subunit from porcine cerebral cortex. Expression of a soluble form of the protein that retains [3H]gabapentin binding activity","volume":"273","author":"Brown","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0896-6273(02)00586-X","article-title":"Theta oscillations in the hippocampus","volume":"33","author":"Buzsaki","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0006-8993(87)91602-7","article-title":"The effect of diazepam on hippocampal EEG in relation to behavior","volume":"435","author":"Caudarella","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib6","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.neuroimage.2007.04.013","article-title":"Neurophysiological correlates of sleepiness: a combined TMS and EEG study","volume":"36","author":"De Gennaro","year":"2007","journal-title":"NeuroImage"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tips.2006.12.006","article-title":"Ca2+ channel \u03b12\u03b4 ligands: novel modulators of neurotransmission","volume":"28","author":"Dooley","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.jcp.0000084032.22282.ff","article-title":"A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder","volume":"23","author":"Feltner","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib9","first-page":"49","article-title":"Hippocampal electrical activity and behavior in the rabbit","volume":"135","author":"Fontani","year":"1997","journal-title":"Arch. Ital. Biol."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib10","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","article-title":"The novel anticonvulsant drug, gabapentin (neurontin), binds to the alpha2delta subunit of a calcium channel","volume":"271","author":"Gee","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib11","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1523\/JNEUROSCI.1211-05.2005","article-title":"State-dependent alterations in hippocampal oscillations in serotonin 1a receptor-deficient mice","volume":"25","author":"Gordon","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1460-9568.1998.00069.x","article-title":"The intermediate stage and paradoxical sleep in the rat: influence of three generations of hypnotics","volume":"10","author":"Gottesmann","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib13","series-title":"The Neuropsychology of Anxiety: an Enquiry into the Functions of the Septo-hippocampal System","author":"Gray","year":"2000"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1152\/jn.1954.17.6.533","article-title":"Hippocampal electrical activity in arousal","volume":"17","author":"Green","year":"1954","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib15","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.neuroscience.2004.03.043","article-title":"Modulation of septo-hippocampal theta activity by GABAA receptors: an experimental and computational approach","volume":"126","author":"Hajos","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0269881107076996","article-title":"An effect-size analysis of pharmacologic treatments for generalized anxiety disorder","volume":"21","author":"Hidalgo","year":"2007","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0922-4106(93)90156-4","article-title":"Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies","volume":"244","author":"Hill","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00000542-200610000-00023","article-title":"Supraspinal anesthesia: behavioral and electroencephalographic effects of intracerebroventricularly infused pentobarbital, propofol, fentanyl, and midazolam","volume":"105","author":"Jugovac","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib19","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0022-3565(24)29233-8","article-title":"Pregabalin enhances nonrapid eye movement sleep","volume":"299","author":"Kubota","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib20","article-title":"Behavioral characterization of pregabalin in congenic \u03b12\u2013\u03b4-1(r217a) mouse mutants in models of anxiety and side effects","author":"Lotarski","year":"2006","journal-title":"Soc. Neurosci. Abstr."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-0327(00)00344-X","article-title":"Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety","volume":"61","author":"McNaughton","year":"2000","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/FBP.0b013e3282ee82e3","article-title":"Elicited hippocampal theta rhythm: a screen for anxiolytic and procognitive drugs through changes in hippocampal function?","volume":"18","author":"McNaughton","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4088\/JCP.v67n0511","article-title":"Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine","volume":"67","author":"Montgomery","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/sleep\/31.1.34","article-title":"Selective 5-HT2a and 5-HT6 receptor antagonists promote sleep in rats","volume":"31","author":"Morairty","year":"2008","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1176\/appi.ajp.160.3.533","article-title":"Pregabalin in generalized anxiety disorder: a placebo-controlled trial","volume":"160","author":"Pande","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00004714-199908000-00010","article-title":"Treatment of social phobia with gabapentin: a placebo-controlled study","volume":"19","author":"Pande","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib27","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/archneurpsyc.1937.02260220069003","article-title":"A proposed mechanism of emotion","volume":"38","author":"Papez","year":"1937","journal-title":"Arch. Neurol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib42","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.jcp.0000155820.74832.b0","article-title":"Efficacy of pregabalin in the treatment of generalized anxiety disorder double-blind, placebo-controlled comparison of bid versus tid dosing","volume":"25","author":"Pohl","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib29","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archpsyc.62.9.1022","article-title":"Pregabalin for treatment of generalized anxiety disorder; a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam","volume":"62","author":"Rickels","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02805968","article-title":"The antiepileptic agent gabapentin (neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by d-serine","volume":"127","author":"Singh","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1460-9568.2005.04560.x","article-title":"Activation of alpha7 acetylcholine receptors augments stimulation-induced hippocampal theta oscillation","volume":"23","author":"Siok","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0922-4106(93)90155-3","article-title":"Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies","volume":"244","author":"Suman-Chauhan","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel \u03b12\u2013\u03b4 (alpha2\u2013delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.neuropharm.2006.09.022","article-title":"Pharmacological and computational analysis of alpha-subunit preferential GABA(A) positive allosteric modulators on the rat septo-hippocampal activity","volume":"52","author":"Ujfalussy","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuropharm.2004.03.017","article-title":"Effects of diazepam and zolpidem on EEG beta frequencies are behavior-specific in rats","volume":"47","author":"van Lier","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0306-4522(01)00448-1","article-title":"GABA(B) receptors in the median raphe nucleus: distribution and role in the serotonergic control of hippocampal activity","volume":"109","author":"Varga","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2005.11.001","article-title":"Activity profile of pregabalin in rodent models of epilepsy and ataxia","volume":"68","author":"Vartanian","year":"2005","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0301-0082(82)90005-3","article-title":"Brain stem generation of the hippocampal EEG","volume":"19","author":"Vertes","year":"1982","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2008.09.013_bib39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hipo.20118","article-title":"Hippocampal theta rhythm: a tag for short-term memory","volume":"15","author":"Vertes","year":"2005","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib40","first-page":"893","article-title":"Brainstem\u2013diencephalo\u2013septohippocampal systems controlling the theta rhythm of the hippocampus","volume":"81","author":"Vertes","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.09.013_bib41","doi-asserted-by":"crossref","first-page":"10670","DOI":"10.1523\/JNEUROSCI.1987-04.2004","article-title":"Interactions between GABAergic and cholinergic processes in the nucleus pontis oralis: neuronal mechanisms controlling active (rapid eye movement) sleep and wakefulness","volume":"24","author":"Xi","year":"2004","journal-title":"J. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808004152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808004152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T14:15:49Z","timestamp":1738419349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390808004152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0028390808004152"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2008.09.013","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}